Adagio Medical Holdings, Inc. ADGM · Stock Open Adagio Medical Holdings, Inc. in new tab
Adagio Medical Holdings, Inc. Analysis (ADGM)
Is Adagio Medical Holdings, Inc. a good investment? Adagio Medical Holdings, Inc. (ADGM) is currently trading at 0.6510 USD.
Earnings Schedule: Adagio Medical Holdings, Inc. is expected to release its next earnings report on Nov. 11, 2026.
Investor FAQ
Does Adagio Medical Holdings, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Adagio Medical Holdings, Inc.?
Adagio Medical Holdings, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 11, 2026. The company currently has a trailing EPS of -2.76.
Company Profile
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. The company was founded in 2011 and is headquartered in Laguna Hills, California.
Community Discussion